Massimo S. Fiandaca

6.1k total citations · 2 hit papers
72 papers, 4.2k citations indexed

About

Massimo S. Fiandaca is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Massimo S. Fiandaca has authored 72 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 28 papers in Neurology and 23 papers in Cellular and Molecular Neuroscience. Recurrent topics in Massimo S. Fiandaca's work include Neurological disorders and treatments (18 papers), Nerve injury and regeneration (14 papers) and Neurogenesis and neuroplasticity mechanisms (9 papers). Massimo S. Fiandaca is often cited by papers focused on Neurological disorders and treatments (18 papers), Nerve injury and regeneration (14 papers) and Neurogenesis and neuroplasticity mechanisms (9 papers). Massimo S. Fiandaca collaborates with scholars based in United States, France and United Kingdom. Massimo S. Fiandaca's co-authors include Howard J. Federoff, Mark Mapstone, Krystof S. Bankiewicz, Amrita K. Cheema, John Forsayeth, Don M. Gash, John T. Hansen, Edward J. Goetzl, Janice B. Schwartz and Erin L. Abner and has published in prestigious journals such as Nature Medicine, PLoS ONE and NeuroImage.

In The Last Decade

Massimo S. Fiandaca

72 papers receiving 4.1k citations

Hit Papers

Plasma phospholipids identify antecedent memory impairmen... 2014 2026 2018 2022 2014 2014 250 500 750

Peers

Massimo S. Fiandaca
Yun Joong Kim South Korea
Ronald G. Haller United States
Mark L. Cohen United States
Geoffrey Murdoch United States
Massimo S. Fiandaca
Citations per year, relative to Massimo S. Fiandaca Massimo S. Fiandaca (= 1×) peers Hiroki Namba

Countries citing papers authored by Massimo S. Fiandaca

Since Specialization
Citations

This map shows the geographic impact of Massimo S. Fiandaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo S. Fiandaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo S. Fiandaca more than expected).

Fields of papers citing papers by Massimo S. Fiandaca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo S. Fiandaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo S. Fiandaca. The network helps show where Massimo S. Fiandaca may publish in the future.

Co-authorship network of co-authors of Massimo S. Fiandaca

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo S. Fiandaca. A scholar is included among the top collaborators of Massimo S. Fiandaca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo S. Fiandaca. Massimo S. Fiandaca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laar, Amber D. Van, Chadwick W. Christine, Nicolás Phielipp, et al.. (2025). Intraputaminal Delivery of Adeno‐Associated Virus Serotype 2Glial Cell Line–Derived Neurotrophic Factor in Mild or Moderate Parkinson's Disease. Movement Disorders. 40(7). 1297–1306. 4 indexed citations
2.
Barker, Roger A., Märt Saarma, Clive N. Svendsen, et al.. (2024). Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop. Journal of Parkinson s Disease. 14(8). 1659–1676. 3 indexed citations
3.
Laar, Amber D. Van, Chadwick W. Christine, Nicolás Phielipp, et al.. (2024). AAV2-GDNF Gene Delivery in Mild- and Moderate-Stages of Parkinson’s Disease: Preliminary Brain Imaging and Clinical Outcomes. Parkinsonism & Related Disorders. 122. 106134–106134. 1 indexed citations
4.
Macciardi, Fabìo, Maria Giulia Bacalini, Ricardo Miramontes, et al.. (2022). A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease. GeroScience. 44(3). 1525–1550. 25 indexed citations
5.
Ehrlich, Debra, Codrin Lungu, Russell R. Lonser, et al.. (2022). Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson’s disease. Molecular Therapy. 30(12). 3632–3638. 31 indexed citations
6.
Fiandaca, Massimo S., Mark Mapstone, Amin Mahmoodi, et al.. (2018). Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls. PLoS ONE. 13(4). e0195318–e0195318. 30 indexed citations
7.
Groß, Thomas, Mark Mapstone, Ricardo Miramontes, et al.. (2018). Toward Reproducible Results from Targeted Metabolomic Studies: Perspectives for Data Pre-processing and a Basis for Analytic Pipeline Development. Current Topics in Medicinal Chemistry. 18(11). 883–895. 13 indexed citations
8.
Edwardson, Matthew A., Xiaogang Zhong, Massimo S. Fiandaca, et al.. (2018). Plasma microRNA markers of upper limb recovery following human stroke. Scientific Reports. 8(1). 12558–12558. 18 indexed citations
9.
Fiandaca, Massimo S., Mark Mapstone, Mireille Jacobson, et al.. (2017). Systems healthcare: a holistic paradigm for tomorrow. BMC Systems Biology. 11(1). 142–142. 24 indexed citations
10.
Passini, Marco A., Jie Bu, Amy M. Richards, et al.. (2014). Translational Fidelity of Intrathecal Delivery of Self-Complementary AAV9–Survival Motor Neuron 1 for Spinal Muscular Atrophy. Human Gene Therapy. 25(7). 619–630. 72 indexed citations
11.
Mapstone, Mark, Amrita K. Cheema, Massimo S. Fiandaca, et al.. (2014). Plasma phospholipids identify antecedent memory impairment in older adults. Nature Medicine. 20(4). 415–418. 782 indexed citations breakdown →
12.
Fiandaca, Massimo S. & Howard J. Federoff. (2013). Using viral-mediated gene delivery to model Parkinson's disease: Do nonhuman primate investigations expand our understanding?. Experimental Neurology. 256. 117–125. 5 indexed citations
13.
Ziegler, Robin J., Ernesto A. Salegio, James C. Dodge, et al.. (2011). Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion. Experimental Neurology. 231(2). 261–271. 23 indexed citations
14.
Yin, Dali, Francisco Valles, Massimo S. Fiandaca, et al.. (2009). Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. NeuroImage. 54. S196–S203. 50 indexed citations
15.
Fiandaca, Massimo S., John Forsayeth, Peter J. Dickinson, & Krystof S. Bankiewicz. (2008). Image-Guided Convection-Enhanced Delivery Platform in the Treatment of Neurological Diseases. Neurotherapeutics. 5(1). 123–127. 104 indexed citations
16.
Fiandaca, Massimo S., Vanja Varenika, Jamie L. Eberling, et al.. (2008). Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. NeuroImage. 47. T27–T35. 96 indexed citations
17.
Fiandaca, Massimo S.. (1991). BRAIN GRAFTING FOR PARKINSONʼS DISEASE. Transplantation. 51(3). 549–556. 10 indexed citations
18.
Kordower, Jeffrey H. & Massimo S. Fiandaca. (1990). Response of the monkey cholinergic septohippocampal system to fornix transection: A histochemical and cytochemical analysis. The Journal of Comparative Neurology. 298(4). 443–457. 25 indexed citations
19.
Fiandaca, Massimo S., Jeffrey H. Kordower, John T. Hansen, Shoushu Jiao, & Don M. Gash. (1988). Adrenal medullary autografts into the basal ganglia of Cebus monkeys: Injury-induced regeneration. Experimental Neurology. 102(1). 76–91. 158 indexed citations
20.
Mizuno, Junichi, et al.. (1988). Recurrent intramedullary enterogenous cyst of the cervical spinal cord. Child s Nervous System. 4(1). 47–49. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026